A peer-reviewed study from Japan, published in Cureus, has found that approximately 70% of deaths following the Pfizer COVID-19 vaccine occurred within the first ten days after vaccination. Researchers examined the correlation between deaths and the Pfizer vaccine, focusing on cases reported between February 2021 and March 2023.
This follows a global outcry against forced vaccination in South America, Asia, and Africa.
The study divided participants into groups aged 65 and above (Group 1) and those under 64 (Group 2). In Group 1, there were 1,311 deaths, while Group 2 saw 247 deaths. The researchers reported that 71% of deaths in Group 1 and 70% in Group 2 occurred within the first ten days after vaccination, with a notable spike on the first, third, and fourth days.
Also read: Experts condemn LASG’s HPV vaccine push in schools, cites health, ethical concer
Other sources revealed that autopsies were conducted in only eight of 239 unexplained deaths in Group 1, with ischemic heart disease, heart failure, and aspiration pneumonia cited as the leading causes of death in the elderly. Similarly, in Group 2, men were more likely to die than women, with ischemic heart disease, cardiac arrhythmias, and myocarditis being the most frequent causes.
The study highlighted that myocarditis, particularly in younger men, was a significant risk factor within the first ten days. Researchers speculated that undiagnosed myocarditis or pericarditis cases could contribute to the higher male death rates.
Also read: Experts warn of serious risks with FDA-approved Mpox vaccine
The study acknowledged its limitations, including a narrow focus on deaths within the first ten days post-vaccination and the absence of mortality rates in the analysis. The researchers also warned that not all deaths reported to Japan’s Ministry of Health, Labor, and Welfare were directly linked to the vaccine and that the results should be interpreted cautiously.
While the study emphasized that vaccines generally require a higher level of safety than therapeutic drugs, it underscored the importance of using statistical methods to assess vaccine-related deaths and improve safety evaluations.